In this 18 minute video interview, Dr Susan O’Brien of MD Anderson, discusses some of the CLL data presented at ASCO 2013 and shares her perspective on several of the exciting new targeted agents in development, including some good news for those of us with co-morbidities.
pharmastrategyblog.com/2013...
Neil (with thanks from a fellow Aussie John from our sunshine state, for drawing my attention to this video)
As I have posted before, if Dr Susan O'Brien talks, it is time to listen.
Apart from being tremendously impressed with her range of knowledge, this video clearly shows the advances made in formulating a treatment for CLL. There are very good reasons to be optimistic that a simple pill will one day be able to put CLL into remission.
Scroll down on the video page and there is a link to tumur lysis syndrome that I posted about earlier.
Dick
Prof Dr Susan O'Brien - Lessons Learned From the CAPTIVATE Trial of Ibrutinib Plus Venetoclax in CLL
ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)
CLL Society Dr. Koffman's ASCO 2020 "Top 12" Picks #s 12, 11, 10ASH 2012 Interview: Dr Jeff Sharman "Why New CLL Treatments Supersede FCR"MRD assessment in CLL
